Moderna (MRNA)

Other Income/Expenses (Net)

$48.00M

Quarterly · Period ending: · USD

MRNA logo

MRNA Other Income/Expenses (Net)

Latest reported$48.00M
MRNA Quarterly Other Income/Expenses (Net) ($3.28M → $48.00M)
High-resolution chart · PNG

MRNA other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
48,000,000
54,000,000
58,000,000
73,000,000
89,000,000
86,000,000
62,000,000
91,000,000
84,000,000
101,000,000
64,000,000
54,000,000
118,000,000
61,000,000
75,000,000
51,000,000
27,000,000
2,000,000
0
-6,000,000
1,000,000
-6,000,000
4,026,000
2,345,000
5,562,000
6,698,000
7,097,000
7,371,000
8,445,000
9,041,000
11,773,000
5,487,000
6,572,000
5,026,000
3,713,000
3,085,000
3,281,000
3,281,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.